PAPER Lee DS, Choi J, Kim SH, Kim S
SEARCH RESULTS
331395 RESULTS
PAPER
Drugs to treat Alzheimer's disease.
J Psychosoc Nurs Ment Health Serv. 2014 Apr;52(4):21-2. PubMed: 24694467PAPER de Rivero Vaccari JP, Brand FJ 3rd, Sedaghat C, Mash DC, Dietrich WD, Keane RW
RIG-1 receptor expression in the pathology of Alzheimer's disease.
J Neuroinflammation. 2014 Apr 2;11:67. PubMed: 24694234PAPER Shen CP, Lin WY, Lin TF, Wang WF, Tsai CH, Hsu BD, Huang CY, Liu HP, Tsai FJ
Association of genetic variants in senataxin and Alzheimer's disease in a Chinese Han population in Taiwan.
Chin J Physiol. 2014 Apr 30;57(2):83-9. PubMed: 24694197PAPER Guzmán EA, Bouter Y, Richard BC, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Wirths O, Bayer TA
Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
Mol Neurodegener. 2014 Apr 2;9:13. PubMed: 24694184PAPER Wang G, Zhou Y, Huang FJ, Tang HD, Xu XH, Liu JJ, Wang Y, Deng YL, Ren RJ, Xu W, Ma JF, Zhang YN, Zhao AH, Chen SD, Jia W
Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
J Proteome Res. 2014 May 2;13(5):2649-58. Epub 2014 Apr 14 PubMed: 24694177PAPER Yin J, Turner GH, Coons SW, Maalouf M, Reiman EM, Shi J
Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice.
Curr Alzheimer Res. 2014 Mar;11(3):283-90. PubMed: 24694076PAPER Becker RE, Greig NH
A new regulatory road-map for Alzheimer's disease drug development.
Curr Alzheimer Res. 2014 Mar;11(3):215-20. PubMed: 24694075PAPER Doi T, Shimada H, Makizako H, Tsutsumimoto K, Uemura K, Anan Y, Suzuki T
Cognitive function and gait speed under normal and dual-task walking among older adults with mild cognitive impairment.
BMC Neurol. 2014 Apr 1;14:67. PubMed: 24694100PAPER Rohn TT, Day RJ, Sheffield CB, Rajic AJ, Poon WW
Apolipoprotein E pathology in vascular dementia.
Int J Clin Exp Pathol. 2014;7(3):938-47. Epub 2014 Feb 15 PubMed: 24696712PAPER Klingelhoefer L, Sokolov E, Chaudhuri KR
Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders.
J Neural Transm. 2014 Apr 3; PubMed: 24696217PAPER Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy.
Nature. 2014 May 1;509(7498):105-9. Epub 2014 Mar 30 PubMed: 24695223PAPER M B, E L, C K, R MN, S PA, J R, K SS
Embryonic stem cell-derived neurons as a novel cellular model system to study neurodegenerative and neuroregenerative processes in vitro.
J Stem Cells Regen Med. 2007;2(1):62-3. Epub 2007 May 16 PubMed: 24692907PAPER Spalletta G, Robinson RG, Cravello L, Pontieri FE, Pierantozzi M, Stefani A, Long JD, Caltagirone C, Assogna F
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease.
J Neurol. 2014 Apr 3; PubMed: 24695996PAPER Ray S, Bender S, Kang S, Lin R, Glicksman MA, Liu M
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.
J Biol Chem. 2014 May 9;289(19):13042-53. Epub 2014 Apr 2 PubMed: 24695735Current Filters
No filters selected